Extranucleolar CYCLON Staining Pattern Is Strongly Associated to Relapse/Refractory Disease in R-CHOP-treated DLBCL.

Saved in:
Bibliographic Details
Title: Extranucleolar CYCLON Staining Pattern Is Strongly Associated to Relapse/Refractory Disease in R-CHOP-treated DLBCL.
Authors: Bouroumeau A; Department of Cytology and Pathology, Grenoble-Alpes University Hospital, Grenoble, France.; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France., Bussot L; Department of Clinical Hematology, Grenoble-Alpes University Hospital, Grenoble, France., Sartelet H; Department of Cytology and Pathology, Grenoble-Alpes University Hospital, Grenoble, France., Fournier C; Unit for Innovation in Genetics and Epigenetics in Oncology and Dijon University Hospital, University of Bourgogne, INSERM 1231, Dijon, France., Betton-Fraisse P; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France., Col E; Department of Cytology and Pathology, Grenoble-Alpes University Hospital, Grenoble, France., David-Boudet L; Department of Cytology and Pathology, Grenoble-Alpes University Hospital, Grenoble, France., McLeer A; Department of Cytology and Pathology, Grenoble-Alpes University Hospital, Grenoble, France.; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France., Lefebvre C; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France.; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, Grenoble, France., Raskovalova T; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, Grenoble, France., Jacob MC; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, Grenoble, France., Vettier C; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, Grenoble, France., Chevalier S; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, Grenoble, France., Algrin C; Daniel Hollard Institute, Grenoble, France., Carras S; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France.; Department of Clinical Hematology, Grenoble-Alpes University Hospital, Grenoble, France.; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, Grenoble, France., Gressin R; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France.; Department of Clinical Hematology, Grenoble-Alpes University Hospital, Grenoble, France., Callanan MB; Unit for Innovation in Genetics and Epigenetics in Oncology and Dijon University Hospital, University of Bourgogne, INSERM 1231, Dijon, France., Bonnefoix T; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France.; Pole Recherche, Grenoble-Alpes University Hospital, Grenoble, France., Emadali A; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France.; Pole Recherche, Grenoble-Alpes University Hospital, Grenoble, France.
Source: HemaSphere [Hemasphere] 2021 Jun 12; Vol. 5 (7), pp. e598. Date of Electronic Publication: 2021 Jun 12 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2572-9241
DOI:10.1097/HS9.0000000000000598